Cargando…

Development and Characterization of a Preclinical Model of Breast Cancer Lung Micrometastatic to Macrometastatic Progression

Most cancer patients die with metastatic disease, thus, good models that recapitulate the natural process of metastasis including a dormancy period with micrometastatic cells would be beneficial in developing treatment strategies. Herein we report a model of natural metastasis that balances time to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bailey-Downs, Lora C., Thorpe, Jessica E., Disch, Bryan C., Bastian, Anja, Hauser, Paul J., Farasyn, Taleah, Berry, William L., Hurst, Robert E., Ihnat, Michael A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4039511/ https://www.ncbi.nlm.nih.gov/pubmed/24878664 http://dx.doi.org/10.1371/journal.pone.0098624

Ejemplares similares

Solid phase synthesis and biological evaluation of probestin as an angiogenesis inhibitor
por: Pathuri, Gopal, et al.
Publicado: (2013)

Identification of novel drugs to target dormant micrometastases
por: Hurst, Robert E., et al.
Publicado: (2015)

Characterisation of micrometastatic tumor cells
por: Pantel, K
Publicado: (2000)

Putative growth characteristics of micrometastatic breast cancer
por: Chambers, Ann F, et al.
Publicado: (2008)

Treatment with proteasome inhibitor bortezomib decreases organic anion transporting polypeptide (OATP) 1B3-mediated transport in a substrate-dependent manner
por: Alam, Khondoker, et al.
Publicado: (2017)

Application of OSNA Nomogram in Patients With Macrometastatic Sentinel Lymph Node: A Retrospective Assessment of Accuracy
por: Combi, Francesca, et al.
Publicado: (2021)

Generation and Characterization of a JAK2V617F-Containing Erythroleukemia Cell Line
por: Zhao, Wanke, et al.
Publicado: (2014)

Might positron emission tomography actually treat micrometastatic cancer?
por: Goldstein, Mark R., et al.
Publicado: (2009)

AIM1 is an actin-binding protein that suppresses cell migration and micrometastatic dissemination
por: Haffner, Michael C., et al.
Publicado: (2017)

Micrometastatic spread in breast cancer: detection, molecular characterization and clinical relevance
por: Fehm, Tanja, et al.
Publicado: (2008)

Low specificity of PGP9.5 expression for detection of micrometastatic neuroblastoma.
por: Gilbert, J., et al.
Publicado: (1997)

Liver Colonization by Colorectal Cancer Metastases Requires YAP-Controlled Plasticity at the Micrometastatic Stage
por: Heinz, Maria C., et al.
Publicado: (2022)

High-resolution array comparative genomic hybridization of single micrometastatic tumor cells
por: Fuhrmann, Christine, et al.
Publicado: (2008)

Detection of micrometastatic prostate cancer cells in the bone marrow of patients with prostate cancer.
por: Deguchi, T., et al.
Publicado: (1997)

The Emerging Role of Platelets in the Formation of the Micrometastatic Niche: Current Evidence and Future Perspectives
por: Gkolfinopoulos, Stavros, et al.
Publicado: (2020)

AG488 as a therapy against gliomas
por: Ziegler, Jadith, et al.
Publicado: (2017)

Prognostic relevance of urokinase plasminogen activator detection in micrometastatic cells in the bone marrow of patients with primary breast cancer.
por: Solomayer, E. F., et al.
Publicado: (1997)

Auger radiopharmaceutical therapy targeting prostate-specific membrane antigen in a micrometastatic model of prostate cancer
por: Shen, Colette J., et al.
Publicado: (2020)

Prognosis and local treatment strategies of breast cancer patients with different numbers of micrometastatic lymph nodes
por: Luo, Shiping, et al.
Publicado: (2023)

Decreased Survival of Invasive Ductal Breast Cancer Patients With Two Macrometastatic Lymph Nodes Among Few Resected Ones: Should Current Sentinel-Lymph-Node Guidelines Be Revised?
por: Luz, Felipe A. C., et al.
Publicado: (2021)

Residual lymph node tumour burden following removal of a single axillary sentinel lymph with macrometastatic disease in women with screen-detected invasive breast cancer
por: Dave, R V, et al.
Publicado: (2020)

Bilateral ovarian micrometastatic adenocarcinoma upon prophylactic oophorectomy concurrent with low anterior resection for rectal cancer
por: Irons, Robin, et al.
Publicado: (2017)

Pathological Evidence for Residual SARS-CoV-2 in the Micrometastatic Niche of a Patient with Ovarian Cancer
por: Hayashi, Takuma, et al.
Publicado: (2022)

Corrigendum: Decreased Survival of Invasive Ductal Breast Cancer Patients With Two Macrometastatic Lymph Nodes Among Few Resected Ones: Should Current Sentinel-Lymph-Node Guidelines Be Revised?
por: Luz, Felipe A. C., et al.
Publicado: (2021)

Identifying high-risk stage IIIA cutaneous melanoma patients who might benefit from adjuvant therapy: the importance of micrometastatic tumor burden
por: Egger, Michael E.
Publicado: (2023)

Identifying biomarkers of breast cancer micrometastatic disease in bone marrow using a patient-derived xenograft mouse model
por: Pillai, Sreeraj G., et al.
Publicado: (2018)

Less micrometastatic risk related to circulating tumor cells after endoscopic breast cancer surgery compared to open surgery
por: Li, Shichao, et al.
Publicado: (2019)

Prognostic and Predictive Value of the American Joint Committee on Cancer Pathological Prognostic Staging System in Nodal Micrometastatic Breast Cancer
por: Shi, Jian, et al.
Publicado: (2020)

Effect of different cytokines on mammaglobin and maspin gene expression in normal leukocytes: possible relevance to the assays for the detection of micrometastatic breast cancer
por: Ballestrero, A, et al.
Publicado: (2005)

A Retrospective Study of the Impact of 21-Gene Recurrence Score Assay on Treatment Choice in Node Positive Micrometastatic Breast Cancer
por: Frazier, Thomas G., et al.
Publicado: (2015)

Circulating tumor DNA analysis detects micrometastatic disease and predicts recurrence in a patient with colon cancer: A case report
por: Luo, Jiamin, et al.
Publicado: (2023)

Regional nodal irradiation (RNI) in breast cancer patients with residual isolated tumor cells or micrometastatic nodal disease after neoadjuvant chemotherapy
por: Kim, Joseph K., et al.
Publicado: (2022)

Cure of Micrometastatic B-Cell Lymphoma in a SCID Mouse Model Using (213)Bi-Anti-CD20 Monoclonal Antibody
por: Havlena, Gregory T., et al.
Publicado: (2023)

Release of Myofascial Pain with Deep Cross-Friction Named “Roptrotherapy”
por: Farasyn, Andre
Publicado: (2010)

TNF-Alpha as an Initiator of Allodynia and Anxiety-Like Behaviors in a Preclinical Model of PTSD and Comorbid Pain
por: Dib, Patrick, et al.
Publicado: (2021)

A long-term "memory" of HIF induction in response to chronic mild decreased oxygen after oxygen normalization
por: Kamat, Chandrashekhar D, et al.
Publicado: (2007)

Suppression and Activation of the Malignant Phenotype by Extracellular Matrix in Xenograft Models of Bladder Cancer: A Model for Tumor Cell “Dormancy”
por: Hurst, Robert E., et al.
Publicado: (2013)

Benefits and drawbacks of electronic health record systems
por: Menachemi, Nir, et al.
Publicado: (2011)

A new anti-glioma therapy, AG119: pre-clinical assessment in a mouse GL261 glioma model
por: Towner, Rheal A., et al.
Publicado: (2015)

Innovative Approaches in the Battle Against Cancer Recurrence: Novel Strategies to Combat Dormant Disseminated Tumor Cells
por: Sauer, Scott, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_gp6sd6q0u6g03pfrlisvnbseoa